Inspire Medical Systems, Inc. Investment Income, Interest and Dividend
Inspire Medical Systems, Inc. (INSP) reported Investment Income, Interest and Dividend of $3.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2026-08-03
- Inspire Medical Systems, Inc. investment income, interest and dividend for the quarter ending 2026-06-30 was $3.74M, a 16.58% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest and dividend for the quarter ending 2026-03-31 was $3.74M, a 26.15% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest and dividend for the quarter ending 2025-12-31 was $4.00M, a 27.95% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest and dividend for the quarter ending 2025-09-30 was $3.98M, a 32.36% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest and dividend for fiscal 2025 was $17.54M, a 24.57% decline from fiscal 2024.
- Inspire Medical Systems, Inc. investment income, interest and dividend for fiscal 2024 was $23.25M, a 13.07% increase from fiscal 2023.
- Inspire Medical Systems, Inc. investment income, interest and dividend for fiscal 2023 was $20.56M, a 307.13% increase from fiscal 2022.
- Inspire Medical Systems, Inc. investment income, interest and dividend for fiscal 2022 was $5.05M, a 3940.00% increase from fiscal 2021.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 3 month as first filed | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 6 month as first filed | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.74M 10-Q · filed 2026-08-03 | $7.48M 10-Q · filed 2026-08-03 | $11.48M derived: sum of 3 quarters · filed 2026-08-03 | $15.46M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $3.74M 10-Q · filed 2026-05-04 | $7.74M derived: sum of 2 quarters · filed 2026-05-04 | $11.72M derived: sum of 3 quarters · filed 2026-05-04 | $16.21M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $7.98M derived: sum of 2 quarters · filed 2026-02-13 | $12.47M derived: sum of 3 quarters · filed 2026-08-03 | $17.54M 10-K · filed 2026-02-13 | ||
| 2025-09-30 | $3.98M 10-Q · filed 2025-11-03 | $8.47M derived: sum of 2 quarters · filed 2026-08-03 | $13.54M 10-Q · filed 2025-11-03 | $19.08M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $4.48M 10-Q · filed 2026-08-03 | $4.49M 10-Q · filed 2025-08-04 | $9.55M 10-Q · filed 2026-08-03 | $9.55M 10-Q · filed 2025-08-04 | $15.10M derived: sum of 3 quarters · filed 2026-08-03 | $20.99M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $5.07M 10-Q · filed 2026-05-04 | $10.62M derived: sum of 2 quarters · filed 2026-05-04 | $16.51M derived: sum of 3 quarters · filed 2026-05-04 | $22.39M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $11.44M derived: sum of 2 quarters · filed 2026-02-13 | $17.32M derived: sum of 3 quarters · filed 2026-02-13 | $23.25M 10-K · filed 2026-02-13 | ||
| 2024-09-30 | $5.89M 10-Q · filed 2025-11-03 | $11.77M derived: sum of 2 quarters · filed 2025-11-03 | $17.70M 10-Q · filed 2025-11-03 | $23.57M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-06-30 | $5.88M 10-Q · filed 2025-08-04 | $11.80M 10-Q · filed 2025-08-04 | $17.68M derived: sum of 3 quarters · filed 2026-02-13 | $23.17M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-03-31 | $5.92M 10-Q · filed 2025-05-05 | $11.79M derived: sum of 2 quarters · filed 2026-02-13 | $17.29M derived: sum of 3 quarters · filed 2026-02-13 | $22.21M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2023-12-31 | $5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $11.37M derived: sum of 2 quarters · filed 2026-02-13 | $16.29M derived: sum of 3 quarters · filed 2026-02-13 | $20.56M 10-K · filed 2026-02-13 | ||
| 2023-09-30 | $5.50M 10-Q · filed 2024-11-04 | $10.42M derived: sum of 2 quarters · filed 2024-11-04 | $14.69M 10-Q · filed 2024-11-04 | $18.06M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-06-30 | $4.92M 10-Q · filed 2024-08-06 | $9.20M 10-Q · filed 2024-08-06 | $12.56M derived: sum of 3 quarters · filed 2025-02-10 | $13.91M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-03-31 | $4.27M 10-Q · filed 2024-05-07 | $7.64M derived: sum of 2 quarters · filed 2025-02-10 | $8.99M derived: sum of 3 quarters · filed 2025-02-10 | $9.29M derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2022-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $4.72M derived: sum of 2 quarters · filed 2025-02-10 | $5.02M derived: sum of 3 quarters · filed 2025-02-10 | $5.05M 10-K · filed 2025-02-10 | ||
| 2022-09-30 | $1.35M 10-Q · filed 2023-11-07 | $1.65M derived: sum of 2 quarters · filed 2023-11-07 | $1.68M 10-Q · filed 2023-11-07 | $1.70M derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-06-30 | $297.00K 10-Q · filed 2023-08-01 | $331.00K 10-Q · filed 2023-08-01 | $346.00K derived: sum of 3 quarters · filed 2024-02-09 | $368.00K derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-03-31 | $34.00K 10-Q · filed 2023-05-02 | $49.00K derived: sum of 2 quarters · filed 2024-02-09 | $71.00K derived: sum of 3 quarters · filed 2024-02-09 | $102.00K derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2021-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $37.00K derived: sum of 2 quarters · filed 2024-02-09 | $68.00K derived: sum of 3 quarters · filed 2024-02-09 | $125.00K 10-K · filed 2024-02-09 | ||
| 2021-09-30 | $22.00K 10-Q · filed 2022-11-01 | $53.00K derived: sum of 2 quarters · filed 2022-11-01 | $110.00K 10-Q · filed 2022-11-01 | |||
| 2021-06-30 | $31.00K 10-Q · filed 2022-08-02 | $88.00K 10-Q · filed 2022-08-02 | ||||
| 2020-12-31 | $1.09M 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |